ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163443 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163443; 2) Community: the network communities that were significantly associated with the response to NSC 163443; 3) Molecule: the relationships between components within communities and NSC 163443; 4) MDR: the compounds that were significantly associated with the NSC 163443.

NSC Compound Enrichment Correlation
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.00567322425730621 0.24688882
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.00567322425730621 0.27916968
NSC 636969 Null 0.00567322425730621 0.15117803
NSC 63984 Cordycepin 0.00567322425730621 -0.044644662
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.00567322425730621 0.30251379
NSC 407806 .delta.20:22-3,14,21-Trihydroxynorcholenic acid lactone 0.00741876119839022 0.33896205
NSC 639364 2,9-Dimethylellipticinium acetate 0.00741876119839022 -0.17719494
NSC 661415 2-Chloro-3-(2-butoxyethoxy)naphthazarin 0.00741876119839022 0.13683469
NSC 715559 Null 0.00741876119839022 -0.083991921
NSC 728221 5,5-Dimethyl-3-[2-(2,3,5,6-tetrachloro-pyridin-4-ylsulfanyl) -vinyl]-cyclohex-2-enone 0.00741876119839022 0.22716159
Total:30  Current:3    [First] [Prev] [Next] [Last]